Human Growth Hormone-regulated HOXA1 is a Human Mammary Epithelial Oncogene
Xin Zhang,Tao Zhu,Yong Chen,Hichem C. Mertani,Kok-Onn Lee,Peter E. Lobie
DOI: https://doi.org/10.1074/jbc.m212050200
2003-01-01
Abstract:Increased mammary epithelial expression of the human growth hormone (hGH) gene is associated with the acquisition of pathological proliferation. We report here that autocrine hGH production by human mammary carcinoma cells increased the expression and transcriptional activity of the homeobox domain containing protein HOXA1. Forced expression of HOXA1 in human mammary carcinoma cells resulted in increased total cell number primarily by the promotion of cell survival mediated by the transcriptional up-regulation of Bcl-2. HOXA1 also abrogated the apoptotic response of mammary carcinoma cells to doxorubicin. Forced expression of HOXA1 in mammary carcinoma cells, in a Bcl-2-dependent manner, resulted in dramatic enhancement of anchorage-independent proliferation and colony formation in soft agar. Finally, forced expression of HOXA1 was sufficient to result in the oncogenic transformation of immortalized human mammary epithelial cells with aggressive in vivo tumor formation. Herein, we have therefore provided a molecular mechanism by which autocrine hGH stimulation of human mammary epithelial cells may result in oncogenic transformation. Increased mammary epithelial expression of the human growth hormone (hGH) gene is associated with the acquisition of pathological proliferation. We report here that autocrine hGH production by human mammary carcinoma cells increased the expression and transcriptional activity of the homeobox domain containing protein HOXA1. Forced expression of HOXA1 in human mammary carcinoma cells resulted in increased total cell number primarily by the promotion of cell survival mediated by the transcriptional up-regulation of Bcl-2. HOXA1 also abrogated the apoptotic response of mammary carcinoma cells to doxorubicin. Forced expression of HOXA1 in mammary carcinoma cells, in a Bcl-2-dependent manner, resulted in dramatic enhancement of anchorage-independent proliferation and colony formation in soft agar. Finally, forced expression of HOXA1 was sufficient to result in the oncogenic transformation of immortalized human mammary epithelial cells with aggressive in vivo tumor formation. Herein, we have therefore provided a molecular mechanism by which autocrine hGH stimulation of human mammary epithelial cells may result in oncogenic transformation. growth hormone human growth hormone reverse transcriptase fetal bovine serum phosphate-buffered saline bromodeoxyuridine severe combined immunodeficient mice N-[1-(2,3-dioleoyl(oxy)propyl]-N,N,N-triethyl ammonium methyl sulfate Signal transduction pathways that regulate mammary epithelial cell proliferation, differentiation, apoptosis, and transformation have been delineated and utilized as therapeutic targets for the treatment of mammary gland neoplasia (1Pavelic K. Gall-Troselj K. J. Mol. Med. 2001; 79: 566-573Crossref PubMed Scopus (20) Google Scholar, 2Hanahan D. Weinberg R.A. Cell. 2000; 100: 57-70Abstract Full Text Full Text PDF PubMed Scopus (22406) Google Scholar). Examples of such include selective estrogen modulators (3Osborne C.K. Zhao H. Fuqua S.A. J. Clin. Oncol. 2000; 18: 3172-3186Crossref PubMed Scopus (304) Google Scholar) and herceptin (4Pegram M. Slamon D. Semin. Oncol. 2000; 27: 13-19PubMed Google Scholar) targeting estrogen receptor and HER-2 pathways, respectively. However, many carcinomas of the mammary gland neither express the estrogen receptor (5Osborne C.K. Breast Cancer Res. Treat. 1998; 51: 227-238Crossref PubMed Scopus (387) Google Scholar) nor overexpress HER-2 (6Slamon D.J. Clark G.M. Wong S.G. Levin W.J. Ullrich A. McGuire W.L. Science. 1987; 235: 177-182Crossref PubMed Scopus (9954) Google Scholar) and are, therefore, not responsive to these specific therapeutic strategies. Clinical data for the treatment of cancer has clearly demonstrated the superiority of combinatorial therapy over a single-agent approach (7Frei E. Antman K.H. Bast R.C. Kufe D.W. Pollock R.E. Morton D.L. Weichselbaum R.R. Holland J.F. Frei E. Cancer Medicine. 5th Ed. BC Decker, London2000: 556-568Google Scholar). Delineation, characterization. and development of therapeutic regimes targeting novel signaling pathways involved in oncogenic transformation of mammary epithelial cells are therefore required. Growth hormone (GH)1 is obligatory for normal pubertal mammary gland development (8Hull K.L. Harvey S. J. Endocrinol. 2001; 168: 1-23Crossref PubMed Scopus (183) Google Scholar). Specifically, GH acts on both the mammary stromal and epithelial components to result in ductal elongation and the differentiation of ductal epithelia into terminal end buds (9Walden P.D. Ruan W. Feldman M. Kleinberg D.L. Endocrinology. 1998; 139: 659-662Crossref PubMed Scopus (96) Google Scholar, 10Kleinberg D.L. J. Mammary Gland Biol. Neoplasia. 1997; 2: 49-57Crossref PubMed Scopus (86) Google Scholar). Expression of the hGH transgene in mice results in precocious development of the mammary gland (11Bchini O. Andres A.C. Schubaur B. Mehtali M. LeMeur M. Lathe R. Gerlinger P. Endocrinology. 1991; 128: 539-546Crossref PubMed Scopus (43) Google Scholar, 12Tornell J. Rymo L. Isaksson O.G. Int. J. Cancer. 1991; 49: 114-117Crossref PubMed Scopus (47) Google Scholar) and the development of neoplasia (12Tornell J. Rymo L. Isaksson O.G. Int. J. Cancer. 1991; 49: 114-117Crossref PubMed Scopus (47) Google Scholar). Conversely, spontaneous or experimentally engineered functional deficiency of GH (13Nagasawa H. Noguchi Y. Mori T. Niki K. Namiki H. Eur. J. Cancer Clin. Oncol. 1985; 21: 1547-1551Abstract Full Text PDF PubMed Scopus (18) Google Scholar, 14Swanson S.M. Unterman T.G. Carcinogenesis. 2002; 23: 977-982Crossref PubMed Scopus (62) Google Scholar, 15Stavrou S. Kleinberg D.L. Endocrinol. Metab. Clin. North Am. 2001; 30: 545-563Abstract Full Text Full Text PDF PubMed Scopus (26) Google Scholar, 16Okada S. Kopchick J.J. Trends Mol. Med. 2001; 7: 126-132Abstract Full Text Full Text PDF PubMed Scopus (46) Google Scholar) results in severely impaired mammary gland development and virtual resistance to the spontaneous development of hyperplastic alveolar nodules (13Nagasawa H. Noguchi Y. Mori T. Niki K. Namiki H. Eur. J. Cancer Clin. Oncol. 1985; 21: 1547-1551Abstract Full Text PDF PubMed Scopus (18) Google Scholar) and chemically induced mammary carcinogenesis (14Swanson S.M. Unterman T.G. Carcinogenesis. 2002; 23: 977-982Crossref PubMed Scopus (62) Google Scholar, 16Okada S. Kopchick J.J. Trends Mol. Med. 2001; 7: 126-132Abstract Full Text Full Text PDF PubMed Scopus (46) Google Scholar). Similarly, in a primate model, hGH administration results in marked hyperplasia of the mammary gland with an increased epithelial proliferation index (17Ng S.T. Zhou J. Adesanya O.O. Wang J. LeRoith D. Bondy C.A. Nat. Med. 1997; 3: 1141-1144Crossref PubMed Scopus (163) Google Scholar). Thus, the somatotropic axis represents one potential and unutilized approach for novel therapeutic approaches to the treatment of mammary epithelial neoplasia. The hGH gene is also expressed in epithelial cells of the normal human mammary gland (18Raccurt M. Lobie P.E. Moudilou E. Recher S. Garcia-Caballero T. Frappart L. Morel G. Mertani H.C. J. Endocrinol. 2002; 175: 307-318Crossref PubMed Scopus (80) Google Scholar). Increased epithelial expression of the hGH gene is associated with the acquisition of pathological proliferation, and the highest level of hGH gene expression is observed in metastatic mammary carcinoma cells (18Raccurt M. Lobie P.E. Moudilou E. Recher S. Garcia-Caballero T. Frappart L. Morel G. Mertani H.C. J. Endocrinol. 2002; 175: 307-318Crossref PubMed Scopus (80) Google Scholar). hGH receptor gene expression per mammary epithelial cell remains constant throughout the process of neoplastic progression (19Mertani H.C. Garcia-Caballero T. Lambert A. Gerard F. Palayer C. Boutin J.M. Vonderhaar B.K. Waters M.J. Lobie P.E. Morel G. Int. J. Cancer. 1998; 79: 202-211Crossref PubMed Scopus (137) Google Scholar), and therefore, alterations in the local concentration of ligand are likely to be pivotal in determining the effects of hGH on mammary epithelial cell behavior. We have recently generated a model system to study the role of autocrine-produced hGH in mammary carcinoma by stable transfection of either the hGH gene or a translation-deficient hGH gene into mammary carcinoma cells (20Kaulsay K.K. Mertani H.C. Tornell J. Morel G. Lee K.O. Lobie P.E. Exp. Cell Res. 1999; 250: 35-50Crossref PubMed Scopus (102) Google Scholar). The autocrine production of hGH by mammary carcinoma cells results in a hyperproliferative state with marked synergism between trophic agents such as insulin-like growth factor 1 (20Kaulsay K.K. Mertani H.C. Tornell J. Morel G. Lee K.O. Lobie P.E. Exp. Cell Res. 1999; 250: 35-50Crossref PubMed Scopus (102) Google Scholar). The increase in mammary carcinoma cell number as a consequence of autocrine production of hGH is a result of both increased mitogenesis and decreased apoptosis (21Kaulsay K.K. Zhu T. Bennett W. Lee K.O. Lobie P.E. Endocrinology. 2001; 142: 767-777Crossref PubMed Scopus (81) Google Scholar). Thus, autocrine production of hGH by mammary carcinoma cells may direct mammary carcinoma cell behavior to impact on the final clinical prognosis, and therefore, systematic analysis of the relevant mechanistic features by which it exerts its cellular effects is required. One major mechanism by which GH affects cellular and somatic function is by regulating the level of specific mRNA species (22Isaksson O.G. Eden S. Jansson J.O. Annu. Rev. Physiol. 1985; 47: 483-499Crossref PubMed Google Scholar). We have previously utilized cDNA microarray analyses to identify genes regulated by autocrine production of hGH in human mammary carcinoma cells (MCF-7) (23Mertani H.C. Zhu T. Goh E.L. Lee K.O. Morel G. Lobie P.E. J. Biol. Chem. 2001; 276: 21464-21475Abstract Full Text Full Text PDF PubMed Scopus (57) Google Scholar). One gene demonstrated to be up-regulated by autocrine hGH in MCF-7 cells was the homeobox containing transcription factor HOXA1 (23Mertani H.C. Zhu T. Goh E.L. Lee K.O. Morel G. Lobie P.E. J. Biol. Chem. 2001; 276: 21464-21475Abstract Full Text Full Text PDF PubMed Scopus (57) Google Scholar). Homeobox-containing genes are a family of genes encoding transcription factors that possess pivotal roles in development (24Gehring W.J. Hiromi Y. Annu. Rev. Genet. 1986; 20: 147-173Crossref PubMed Scopus (317) Google Scholar). For example, HOXA1 has been demonstrated to be required for vertebrate hindbrain segmentation (25Barrow J.R. Stadler H.S. Capecchi M.R. Development. 2000; 127: 933-944Crossref PubMed Google Scholar). Several reports also suggest the involvement of homeobox-containing genes in the control of cell proliferation and, when dysregulated, in oncogenesis (26Cillo C. Barba P. Freschi G. Bucciarelli G. Magli M.C. Boncinelli E. Int. J. Cancer. 1992; 51: 892-897Crossref PubMed Scopus (136) Google Scholar, 27Abate-Shen C. Nat. Rev. Cancer. 2002; 2: 777-785Crossref PubMed Scopus (500) Google Scholar). Moreover, alterations of HOX gene expression have been detected in a variety of human tumors (26Cillo C. Barba P. Freschi G. Bucciarelli G. Magli M.C. Boncinelli E. Int. J. Cancer. 1992; 51: 892-897Crossref PubMed Scopus (136) Google Scholar, 27Abate-Shen C. Nat. Rev. Cancer. 2002; 2: 777-785Crossref PubMed Scopus (500) Google Scholar, 28Celetti A. Barba P. Cillo C. Rotoli B. Boncinelli E. Magli M.C. Int. J. Cancer. 1993; 53: 237-244Crossref PubMed Scopus (81) Google Scholar), including those of the mammary gland (29Care A. Silvani A. Meccia E. Mattia G. Peschle C. Colombo M.P. Oncogene. 1998; 16: 3285-3289Crossref PubMed Scopus (79) Google Scholar, 30Raman V. Martensen S.A. Reisman D. Evron E. Odenwald W.F. Jaffee E. Marks J. Sukumar S. Nature. 2000; 405: 974-978Crossref PubMed Scopus (406) Google Scholar). Accordingly, HOXA1 has been detected in carcinoma of the mammary gland in the mouse but not in normal mammary tissue (31Friedmann Y. Daniel C.A. Strickland P. Daniel C.W. Cancer Res. 1994; 54: 5981-5985PubMed Google Scholar), and HOXA1 expression has also been detected in neoplastic lesions of the human mammary gland (32Chariot A. Castronovo V. Biochem. Biophys. Res. Comm. 1996; 222: 292-297Crossref PubMed Scopus (60) Google Scholar). Herein we provide a molecular mechanism by which hGH stimulation of human mammary epithelial cells results in oncogenic transformation. hGH-regulated HOXA1 increases mammary epithelial cell number primarily by prevention of apoptotic cell death in a Bcl-2-dependent manner, with resultant anchorage-independent growth and tumor formationin vivo. Functional antagonism of hGH, and the molecular pathways it utilizes, will therefore constitute novel adjunct therapeutic approaches to the treatment of mammary gland neoplasia. The MCF-7 cell line and MCF-10A cell line were obtained from the ATCC. MCF-7 cells and derivatives (see below) were cultured in RPMI 1640 medium supplemented with 10% heat-inactivated fetal bovine serum, 100 IU/ml penicillin, 100 μg/ml streptomycin, and 2 mml-glutamine. MCF-10A cells and derivatives (see below) were cultured in Dulbecco's modified Eagle's medium/F-12 medium (Invitrogen, Carlsbad, CA) supplemented with 5% horse serum (Invitrogen) plus 2 mm glutamine, 100 μg/ml streptomycin, 100 IU/ml penicillin, 0.25 μg/ml ampicillin B, 100 ng/ml cholera toxin, 20 ng/ml epidermal growth factor (Upstate Biotechnology, Lake Placid, NY), 0.5 μg/ml hydrocortisone (Calbiochem, La Jolla, CA), and 10 μg/ml insulin. Fetal bovine serum was purchased from HyClone Laboratories (Logan, UT), and all other cell culture materials were obtained from Sigma Chemical Co. (St. Louis, MO). The MCF-7 cell line was stably transfected with an expression plasmid containing the wild-type hGH gene (pMT-hGH) (33Liu N. Mertani H.C. Norstedt G. Tornell J. Lobie P.E. Exp. Cell Res. 1997; 237: 196-206Crossref PubMed Scopus (50) Google Scholar) under the control of the metallothionein 1a promoter (designated MCF7-hGH) (20Kaulsay K.K. Mertani H.C. Tornell J. Morel G. Lee K.O. Lobie P.E. Exp. Cell Res. 1999; 250: 35-50Crossref PubMed Scopus (102) Google Scholar). For control purposes the ATG start site in pMT-hGH was disabled via a mutation to TTG generated by standard techniques (pMT-MUT) (33Liu N. Mertani H.C. Norstedt G. Tornell J. Lobie P.E. Exp. Cell Res. 1997; 237: 196-206Crossref PubMed Scopus (50) Google Scholar), and MCF-7 cells stably transfected with this plasmid were designated MCF7-MUT. A detailed description of the characterization of these cell lines has been published previously (20Kaulsay K.K. Mertani H.C. Tornell J. Morel G. Lee K.O. Lobie P.E. Exp. Cell Res. 1999; 250: 35-50Crossref PubMed Scopus (102) Google Scholar). MCF-7 and MCF-10A cell lines were stably transfected with an HOXA1 expression plasmid (pSG5-HOXA1) and pcDNA3 empty vector in a ratio of 5:1 by use of Effectene transfection reagent obtained from Qiagen (Hilden, Germany) according to the manufacturer's instruction. pSG5-HOXA1 is the generous gift of Dr. Vincenzo Zappavigna (Milano, Italy). Positive transfectants were selected in 800 μg/ml G418 (Calbiochem) in the appropriate culture medium for the respective cell lines. Individual colonies were selected to determine the HOXA1 expression level. Cell lines were established as MCF7-HOXA1 and MCF10A-HOXA1, respectively, by pooling five individual colonies. Likewise, MCF-7 and MCF-10A cells, stably transfected with vector, were also established (MCF7-VECTOR and MCF10A-VECTOR) as control. Extraction of total RNA and the RT-PCR assay were performed as described previously (23Mertani H.C. Zhu T. Goh E.L. Lee K.O. Morel G. Lobie P.E. J. Biol. Chem. 2001; 276: 21464-21475Abstract Full Text Full Text PDF PubMed Scopus (57) Google Scholar). To compare the PCR products semi-quantitatively, 15–40 cycles of PCR (annealing temperature, 55 °C) were performed to determine the linearity of the PCR amplification, and the amplified β-actin cDNA served as an internal control for cDNA quantity and quality. All RNA samples were treated with DNase I to avoid genomic DNA contamination. The sequences of the oligonucleotide primers used for RT-PCR are as follows: HOXA1 (sense), 5′-GGGAAAGTTGGAGAGTACGGC-3′;HOXA1 (antisense), 5′-CCTCAGTGGGAGGTAGTCAG-3′; β-actin (sense), 5′-ATGATATCGCCGCGCTCG-3′; β-actin (antisense), 5′-CGCTCGGTGAGGATCTTCA-3′;Bcl-2 (sense), 5′-TGCACCTGACGCCCTTCAC-3′; Bcl-2(antisense), 5′-TAGCTGATTCGACGTTTTGCCTGA-3′. Cells were cultured to 40–60% confluence in six-well plates. Transient transfection was performed by use of Effectene as described (23Mertani H.C. Zhu T. Goh E.L. Lee K.O. Morel G. Lobie P.E. J. Biol. Chem. 2001; 276: 21464-21475Abstract Full Text Full Text PDF PubMed Scopus (57) Google Scholar). Briefly, 0.2 μg of the respective luciferase constructs (and other expression constructs as appropriate) were transfected per well in serum-free RPMI medium for 12 h before the medium was changed to fresh serum-free RPMI with or without 50 nm hGH and 10% FBS. After a further 24 h, cells were washed with PBS, and luciferase assays were performed as described previously (34Wood T.J. Sliva D. Lobie P.E. Pircher T.J. Gouilleux F. Wakao H. Gustafsson J.A. Groner B. Norstedt G. Haldosen L.A. J. Biol. Chem. 1995; 270: 9448-9453Abstract Full Text Full Text PDF PubMed Scopus (157) Google Scholar). Results were normalized to the level of β-galactosidase activity and protein concentration in the samples.EphA2-r42B-LUC was a generous gift of Dr. Jin Chen (Nashville, TN), and the PBX1 expression vector was a generous gift of Dr. Vincenzo Zappavigna (Milano, Italy). The Bcl-2 P1 promoter reporter plasmid was a kind gift of Dr. John Kurland (Houston, TX). Cells were treated and harvested as described. Whole cell lysates and crude nuclear extracts were prepared according to the protocol described (23Mertani H.C. Zhu T. Goh E.L. Lee K.O. Morel G. Lobie P.E. J. Biol. Chem. 2001; 276: 21464-21475Abstract Full Text Full Text PDF PubMed Scopus (57) Google Scholar). Proteins were resolved by SDS-polyacrylamide (12%) gel electrophoresis, transferred to a nitrocellulose membrane, and blotted with the antibodies as indicated. The anti-β-actin, anti-HOXA1, and anti-cyclin D1 antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA); the anti-p27Kip1 and anti-p21waf/cip antibodies were from Transduction Laboratories (Lexington, KY); and anti-Fas, anti-Fadd, anti-p53, anti-Bax, anti-Bak, anti-Bcl-2, and anti-Bcl-xL were obtained from Oncogene (San Diego, CA). Immunolabeling was visualized by ECL detection kit from Amersham Biosciences (Little Chalfont, UK) according to the manufacturer's instruction. Mitogenesis was directly assayed by measuring the incorporation of BrdUrd as described (21Kaulsay K.K. Zhu T. Bennett W. Lee K.O. Lobie P.E. Endocrinology. 2001; 142: 767-777Crossref PubMed Scopus (81) Google Scholar). For incorporation of BrdUrd, subconfluent cells were pulse-labeled with 20 mm BrdUrd for 30 min, washed twice with PBS, and fixed in cold 70% ethanol for 30 min. BrdUrd detection was performed by use of the BrdUrd staining kit from Zymed Laboratories Inc. (San Francisco, CA) according to the manufacturer's instructions. A total population of over three times 300 cells was analyzed in several arbitrarily chosen microscopic fields to determine the BrdUrd labeling index (percentage of cells synthesizing DNA). Cells (5 × 104) were seeded into six-well plates in monolayers in serum-free media or in serum-free media supplemented with either 50 nm hGH or 10% FBS. After 48 h, cells were trypsinized with 0.5% trypsin, and the cell number was determined using a hematocytometer. Cells (5 × 104) in suspension culture were grown in 30-mm plastic bacteriological dishes (Sterilin, Teddington, United Kingdom). On the days indicated, cells were harvested and counted as for monolayers. For soft agar colony formation assay, MCF-7 cell and its derived cell lines were cultured in six-well plates first covered with an agar layer (RPMI 1640 with 0.5% agar and 10% FBS). The middle layer contained 5 × 103 cells in RPMI 1640 with 0.35% agar and 10% FBS with or without 50 nm hGH or Bcl-2 inhibitor. Medium was added as the top layer to prevent drying of the agarose gels. The MCF10A-VECTOR and MCF10A-HOXA1 cell soft agar colony formation assay were processed the same as above, except that the medium was changed to Dulbecco's modified Eagle's medium/F-12 containing appropriate components as described, and 104cells were seeded to the middle layer of the soft agar. The plates were incubated for 9 days (for MCF-7 cells) or 14 days (for MCF-10A cells), after which the cultures were inspected and photographed. Apoptotic cell death was measured by fluorescent microscopic analysis of cell DNA staining patterns with Hoechst 33258 from Sigma Chemical Co. (St Louis, MO) (35Del Bino G. Darzynkiewicz Z. Degraef C. Mosselmans R. Fokan D. Galand P. Cell Prolif. 1999; 32: 25-37Crossref PubMed Scopus (98) Google Scholar). Cells were trypsinized with 0.5% trypsin and washed twice with serum-free medium. The cells were then seeded to glass cover slips in six-well plates and incubated in serum-free medium with or without 50 nm hGH, 10% FBS, doxorubicin, Bcl-2 inhibitor (Calbiochem), orBcl-2 antisense oligonucleotide (Calbiochem) as indicated. After a culture period of 24 h, the cells were fixed in 4% paraformaldehyde in PBS (pH 7.4) and stained with the karyophilic dye Hoechst 33258 (20 μg/ml) for 10 min at room temperature. Following washing with PBS, nuclear morphology was examined under a UV-visible fluorescence microscope (Zeiss Axioplan). Apoptotic cells were distinguished from viable cells by their nuclear morphology characterized by nuclear condensation and fragmentation as well as the higher intensity of the blue fluorescence of the nuclei. For statistical analysis, three times 300 cells were counted in eight random microscopic fields at ×400 magnification. Cells were cultured for 24 h in serum-free medium and then transfected with 800 nm oligonucleotide (Calbiochem) for 8 h in DOTAP with a final concentration of 10 μl/ml as previously described (33Liu N. Mertani H.C. Norstedt G. Tornell J. Lobie P.E. Exp. Cell Res. 1997; 237: 196-206Crossref PubMed Scopus (50) Google Scholar): Bcl-2 (sense), 5′-TACCGCGTGCGACCCTCT-3′; Bcl-2 (antisense), 5′-TCTCCCAGCGTGCGCCAT-3′. Severe combined immunodeficient (SCID) 4-week-old mice were purchased from the animal holding facility of the National University of Singapore and acclimated for 7–10 days. For subcutaneous implantation, 5 × 106 control MCF10A-VECTOR or MCF10A-HOXA1 cells were suspended in 100 μl of PBS or Matrigel and injected into the first mammary (axillary) fat pad of SCID mice, which simultaneously received a 60-day release pellet containing 0.72 mg of E2 (Innovative Research of America, Toledo, OH). At necropsy, primary tumors and all organs were evaluated macroscopically for the presence of tumors. Tissue samples of the primary tumor and organs were fixed in 4% paraformaldehyde in PBS (pH 7.4) and embedded in paraffin. Tissue sections of the tumors were stained with H&E to assess morphology. Total RNA extraction and RT-PCR were performed by use of fresh lung and liver tissue to detect possible metastasis of the tumors. All experiments were repeated at least three to five times. All numerical data are expressed as mean ± S.E., and the data were analyzed using Instat 3.0 from GraphPad Software Inc. By use of cDNA microarray analysis we had previously identifiedHOXA1 as an autocrine hGH-regulated gene in human mammary carcinoma cells (23Mertani H.C. Zhu T. Goh E.L. Lee K.O. Morel G. Lobie P.E. J. Biol. Chem. 2001; 276: 21464-21475Abstract Full Text Full Text PDF PubMed Scopus (57) Google Scholar). To verify the autocrine hGH-dependent up-regulation of HOXA1 mRNA observed by cDNA array screening, we first examined the level of HOXA1 mRNA in MCF7-MUT and MCF7-hGH cells by semi-quantitative RT-PCR. The validation that the conditions of RT-PCR used here yielded semi-quantitative estimates of mRNA is described under “Experimental Procedures” and has been utilized previously by us (23Mertani H.C. Zhu T. Goh E.L. Lee K.O. Morel G. Lobie P.E. J. Biol. Chem. 2001; 276: 21464-21475Abstract Full Text Full Text PDF PubMed Scopus (57) Google Scholar, 36Graichen R. Liu D. Sun Y. Lee K.O. Lobie P.E. J. Biol. Chem. 2002; 277: 26662-26672Abstract Full Text Full Text PDF PubMed Scopus (55) Google Scholar). One amplified fragment of the predicted size (359 bp) appropriate for HOXA1mRNA was detected in MCF7-MUT and MCF7-hGH cells (Fig.1 A). Autocrine production of hGH by MCF7-hGH cells resulted in an increased level ofHOXA1 mRNA in comparison to MCF7-MUT cells. Exogenous hGH and FBS also increased HOXA1 mRNA in MCF7-MUT cells and potentiated the increased level of HOXA1 mRNA observed in MCF7-hGH cells due to autocrine production of hGH. The level of β-actin mRNA did not differ between the two cell lines under the different treatment conditions and was used as a control for RNA quality (Fig. 1 A). HOXA1 cDNA transfected into MCF-7 cells results in the appearance of two distinct protein species of 33 and 35 kDa (for example see Fig.2 B) as expected (37Hong Y.S. Kim S.Y. Bhattacharya A. Pratt D.R. Hong W.K. Tainsky M.A. Gene (Amst.). 1995; 159: 209-214Crossref PubMed Scopus (26) Google Scholar). To determine if the autocrine hGH-stimulated increase in HOXA1mRNA also resulted in increased HOXA1 protein, we examined the level of HOXA1 protein in nuclear extracts collected from MCF7-MUT and MCF7-hGH cells by Western blot analysis. Both the 33- and the 35-kDa forms of HOXA1 were detected in nuclear extracts from MCF7-MUT and MCF7-hGH cells (Fig. 1 B) with increased HOXA1 protein observed in MCF7-hGH cells. FBS also increased the level of HOXA1 in MCF7-MUT cells and potentiated the level of HOXA1 in MCF7-hGH cells (Fig. 1 B). Exogenous hGH did not stimulate an increase in HOXA1 protein in MCF7-MUT cells and only minimally enhanced the level in MCF7-hGH cells. To determine if the autocrine hGH-stimulated increase in HOXA1 protein also resulted in increased HOXA1-mediated transcription, we examined luciferase reporter activity from the EphA2-r42B enhancer, which contains four HOX-PBX binding sites (38Chen J. Ruley H.E. J. Biol. Chem. 1998; 273: 24670-24675Abstract Full Text Full Text PDF PubMed Scopus (88) Google Scholar). Autocrine production of hGH by MCF7-hGH cells resulted in increased luciferase activity from the EphA2-r42B enhancer compared with MCF7-MUT cells (Fig.1 C) indicative of increased HOXA1 transcriptional activity. Transient transfection of HOXA1 cDNA increased HOXA1 transcriptional activity in MCF7-MUT cells and dramatically enhanced the already greater HOXA1 transcriptional response in MCF7-hGH cells. Transient transfection of MCF7-MUT cells with PBX1 cDNA was without effect, whereas transient transfection of cDNA for the HOX binding partner PBX1 dramatically increased HOXA1-mediated transcription in MCF7-hGH cells. Transient transfection of MCF7-MUT cells with bothHOXA1 and PBX1 cDNAs did, however, result in a robust transcriptional response through the EphA2-r42Benhancer. Transient transfection of MCF7-hGH cells with bothPBX1 and HOXA1 cDNAs synergistically increased HOXA1-mediated transcription above the enhancement observed with either HOXA1 or PBX1 alone (Fig. 1 C). Thus autocrine hGH production by mammary carcinoma cells results in increased HOXA1-mediated transcriptional activity. To determine the functional consequences of the autocrine hGH-stimulated increased HOXA1 expression in mammary carcinoma cells we generated a mammary carcinoma cell line (MCF-7) with increased expression of HOXA1 by stable transfection ofHOXA1 cDNA (termed MCF7-HOXA1). Forced expression ofHOXA1 mRNA in MCF7-HOXA1 cells compared with vector transfected (MCF7-VECTOR) cells was verified by RT-PCR analysis (Fig.2 A), and MCF7-HOXA1 also demonstrated higher levels of HOXA1 protein compared with MCF7-VECTOR cells (Fig. 2 B). Analysis of HOXA1 transcriptional activity by use of the EphA2-r42Benhancer demonstrated increased HOXA1-mediated transcriptional activity in MCF7-HOXA1 cells compared with MCF7-VECTOR cells under serum-free conditions or when stimulated with exogenous hGH or FBS (Fig.2 C). Transient transfection of cDNA for the HOXA1 binding partner PBX1 in MCF7-VECTOR cells did not alter the level of HOXA1-mediated transcriptional activity under serum-free conditions or exogenous hGH stimulation and only slightly enhanced HOXA1-mediated transcriptional activity of MCF7-VECTOR cells in serum. In contrast, transient transfection of PBX1 cDNA in MCF7-HOXA1 cells synergistically amplified under all conditions, the increased HOXA1-mediated transcription as a result of forced expression of HOXA1 (Fig. 2 C). We therefore examined the effect of forced expression of HOXA1 in mammary carcinoma cells on total cell number. MCF7-VECTOR and MCF7-HOXA1 cells were plated in identical number under serum-free conditions and with either 50 nm exogenous hGH or 10% FBS, and the cell number was determined after 48 h. Exogenous hGH stimulated an increase in MCF7-VECTOR cell number as did FBS (although to a greater extent). MCF7-HOXA1 cells cultured in serum-free media increased in number dramatically more than MCF7-VECTOR cells (Fig.3 A). Exogenous hGH and FBS also increased cell number in MCF7-HOXA1 above that observed in serum-free conditions but similar to the percentage increases observed with hGH and FBS stimulation of MCF7-VECTOR cells. In any case, forced expression of HOXA1 in mammary carcinoma cells resulted in a significant increase in cell number. Increased cell number is achieved by either increased proliferation or decreased apoptotic cell death, and we therefore proceeded to determine the relative contribution of these processes to the observed increase in cell number as a co